Abstract
In woman the risk of the atherosclerosis, particularly coronary heart disease and stroke, osteoporosis increases after the onset of menopause. There is evidence from large studies that a continuaus substitution with estrogen could dramatically decrease the risk of cardiovascular disease and osteoporosis. Many women are reluctant to take estrogenic drugs because of side effects, such as resumption of menstrual bleeding, breast tenderness, and weight gain.
Keywords: Isoflavones, Genistein, daidzein, Menopause, coronary heart disease, Osteoporosis, breast cancer, hrt
SARS-CoV-2/COVID-19
01 December 2021 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.935329
26 November 2021 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.933471
01 December 2021 : Case report
Am J Case Rep 2021; 22:e933458
25 November 2021 : Case report
Am J Case Rep 2021; 22:e933225
In Press
01 Dec 2021 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.935329
01 Dec 2021 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.933078
01 Dec 2021 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.932649
30 Nov 2021 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.934410
Most Viewed Current Articles
15 Aug 2020 : Case report
DOI :10.12659/AJCR.926779
Am J Case Rep 2020; 21:e926779
09 May 2019 : Case report
DOI :10.12659/AJCR.915073
Am J Case Rep 2019; 20:664-667
13 Mar 2019 : Case report
DOI :10.12659/AJCR.914051
Am J Case Rep 2019; 20:330-334
09 Jan 2019 : Case report 
DOI :10.12659/AJCR.912736
Am J Case Rep 2019; 20:36-38